Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) Equity Ratio (2019 - 2025)

Historic Equity Ratio for IDEAYA Biosciences (IDYA) over the last 7 years, with Q4 2025 value amounting to 0.92.

  • IDEAYA Biosciences' Equity Ratio fell 213.34% to 0.92 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.92, marking a year-over-year decrease of 213.34%. This contributed to the annual value of 0.92 for FY2025, which is 213.34% down from last year.
  • Latest data reveals that IDEAYA Biosciences reported Equity Ratio of 0.92 as of Q4 2025, which was down 213.34% from 0.92 recorded in Q3 2025.
  • IDEAYA Biosciences' 5-year Equity Ratio high stood at 0.97 for Q1 2024, and its period low was 0.71 during Q1 2021.
  • Over the past 5 years, IDEAYA Biosciences' median Equity Ratio value was 0.92 (recorded in 2025), while the average stood at 0.89.
  • The largest annual percentage gain for IDEAYA Biosciences' Equity Ratio in the last 5 years was 2262.96% (2021), contrasted with its biggest fall of 2154.47% (2021).
  • Over the past 5 years, IDEAYA Biosciences' Equity Ratio (Quarter) stood at 0.79 in 2021, then rose by 13.92% to 0.9 in 2022, then grew by 6.2% to 0.96 in 2023, then decreased by 1.5% to 0.94 in 2024, then fell by 2.13% to 0.92 in 2025.
  • Its Equity Ratio was 0.92 in Q4 2025, compared to 0.92 in Q3 2025 and 0.92 in Q2 2025.